A new review paper warning manufacturers about the dangers of under-estimating the effects of excipients has received the thumbs up from IPEC.
The report, titled ‘Pharmaceutical excipients – where do we begin?’, explores the cause of a reaction from supposed inert ingredients, concluding that more research must be done to find excipient reactions.
And though the paper – written by Alsion Haywood, senior lecturer at Griffith University, Golden Coast, and Beverley D Glass, professor of pharmacy at James Cook University, Queensland – leaves a broad conclusion to the questions posed, IPEC (international pharmaceutical excipients council) lends its full support.
IPEC chair Patricia Rafidson told in-PharmaTechnologist: “Raising awareness of the use of excipients in context is an important goal of the IPEC Federation.
“This publication recognises the diverse roles excipients may play in pharmaceutical products including the functionality they can impart to dosage forms.
“Initiatives on the prevention of use of falsified medicines will help to reinforce the integrity and robustness of excipient supply which is a high priority for regulators, excipient manufacturers and users.”